Interfraction rotation of the prostate as evaluated by kilovoltage X-ray fiducial marker imaging in intensity-modulated radiotherapy of localized prostate cancer

Medical Dosimetry

Volumn 37, Issue 4, 2012, Pages 396-400

  Graf, Reinhold ^a   Boehmer, Dirk ^a   Budach, Volker ^a   Wust, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Interfraction rotation; KV image guided radiotherapy; On line target localization; Prostate fiducials

Indexed keywords

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DOSIMETRY; FEASIBILITY STUDY; FIDUCIAL MARKER; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTENSITY MODULATED RADIATION THERAPY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIATION FIELD;

DOSE FRACTIONATION; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FIDUCIAL MARKERS; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, IMAGE-GUIDED; REPRODUCIBILITY OF RESULTS; ROTATION; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84868197068     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2012.02.006     Document Type: Article

References (40)

1. Eng T.Y., Luh J.Y., Thomas C.R. The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancer. Curr. Urol. Rep. 2005, 6:194-209.
2. Schallenkamp J.M., Herman M.G., Kruse J.J., et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:800-811.
3. Van Herk M., Remeijer P., Lebesque J.V. Inclusion of geometric uncertainties in treatment plan evaluation. Int. J. Radiat. Oncol. Biol. Phys. 2002, 52:1407-1422.
4. Kutcher G.J., Mageras G.S., Liebel S.A. Control, correction, and modeling of setup errors and organ motion. Semin. Radiat. Oncol. 1995, 5:134-145.
5. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother. Oncol. 2001, 61:127-133.
6. Verellen D., Soete G., Linthout N., et al. Quality assurance of a system for improved target localization and patient set-up that combines real-time infrared tracking and stereoscopic X-ray imaging. Radiother. Oncol. 2003, 67:129-141.
7. Soete G., Verellen D., Michielsen D., et al. Clinical use of stereoscopic X-ray positioning of patients treated with conformal radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002, 54:948-952.
8. Henry A.M., Wilkinson C., Wylie J.P., et al. Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: An assessment of procedure related morbidity, patient acceptability and accuracy. Radiother. Oncol. 2004, 73:57-59.
9. Kupelian P.A., Willoughby T.R., Meeks S.L., et al. Intraprostatic fiducials for localization of the prostate gland: Monitoring intermarker distances during radiation therapy to test for marker stability. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62:1291-1296.
10. Cosgrove V.P., Jahn U., Pfaender M., et al. Commissioning of a micro multi-leaf collimator and planning system for stereotactic radiosurgery. Radiother. Oncol. 1999, 50:325-336.
11. Prescribing, recording and reporting photon beam therapy 1993, International Commission on Radiation Units and Measurements, ICRU Report 50. Bethesda, MD.
12. Soete G., Verellen D., Tournel K., et al. Setup accuracy of stereoscopic X-ray positioning with automated correction for rotational errors in patients treated with conformal arc radiotherapy for prostate cancer. Radiother. Oncol. 2006, 80:371-373.
13. Soete G., Van de Steene J., Verellen D., et al. Initial clinical experience with infrared-reflecting skin markers in the positioning of patients treated by conformal radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002, 52:694-698.
14. Ling C.C., Yorke E., Fuks Z. From IMRT to IGRT: Frontierland or neverland?. Radiother. Oncol. 2006, 78:119-122.
15. Boda-Heggemann J., Köhler F., Wertz H., et al. Fiducial-based quantification of prostate tilt using cone beam computer tomography (CBCT). Radiother. Oncol. 2007, 85:247-250.
16. Beaulieu L., Girouard L.M., Aubin S., et al. Performing daily prostate targeting with a standard V-EPID and an automated radio-opaque marker detection algorithm. Radiother. Oncol. 2004, 73:61-64.
17. Crook J.M., Raymond Y., Salhani D., et al. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother. Oncol. 1995, 37:35-42.
18. Nederveen A.J., Dehnad H., van der Heide U.A., et al. Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. Radiother. Oncol. 2003, 68:81-88.
19. Chung P.W., Haycocks T., Brown T., et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60:329-334.
20. Remeijer P., Geerlof E., Ploeger L., et al. 3-D portal image analysis in clinical practice: An evaluation of 2-D and 3-D analysis techniques as applied to 30 prostate cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 2000, 46:1281-1290.
21. van Herk M., Bruce A., Kroes A.P., et al. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int. J. Radiat. Oncol. Biol. Phys. 1995, 33:1311-1320.
22. Aubry J.F., Beaulieu L., Girouard L.M., et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60:30-39.
23. Linthout N., Verellen D., Tournel K., et al. Assessment of secondary patient motion induced by automated couch movement during on-line 6 dimensional repositioning in prostate cancer treatment. Radiother. Oncol. 2007, 83:168-174.
24. Hoogeman M.S., van Herk M., de Bois J., et al. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother. Oncol. 2005, 74:177-185.
25. Stasi M., Munoz F., Fiorino C., et al. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer. Radiother. Oncol. 2006, 80:363-370.
26. Moiseenko V., Liu M., Kristensen S., et al. Effect of bladder filling on doses to prostate and organs at risk: A treatment planning study. J. Appl. Clin. Med. Phys. 2007, 8:55-68.
27. Engels B., Soete G., Verellen D., et al. Conformal arc radiotherapy for prostate cancer: Increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted Markers. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74:388-391.
28. Van Herk M., Remeijer P., Rasch C., et al. The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2000, 47:1121-1135.
29. Kupelian P.A., Lee C., Langen K.M., et al. Evaluation of image-guidance strategies in the treatment of localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:1151-1157.
30. De Boer H.C., van Os M.J., Jansen P.P., et al. Application of the no action level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers. Int. J. Radiat. Oncol. Biol. Phys. 2005, 6:969-983.
31. Litzenberg D.W., Balter J.M., Lam K.L., et al. Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:123-133.
32. Poulsen P.R., Muren L.P., Høyer M. Residual set-up errors and margins in on-line image-guided prostate localization in radiotherapy. Radiother. Oncol. 2007, 85:201-206.
33. Van Herten Y.R., van de Kamer J.B., van Wieringen N., et al. Dosimetric evaluation of prostate rotations and their correction by couch rotations. Radiother. Oncol. 2008, 88:156-162.
34. Cranmer-Sargison G. A treatment planning investigation into the dosimetric effects of systematic prostate patient rotational set-up errors. Med. Dosim. 2008, 33:19-205.
35. Fu W., Yang Y., Li X., et al. Dosimetric effects of patient rotational setup errors on prostate IMRT treatments. Phys. Med. Biol. 2006, 51:5321-5331.
36. Bos L.J., van der Geer J., van Herk M., et al. The sensitivity of dose distributions for organ motion and set-up uncertainties in prostate IMRT. Radiother. Oncol. 2005, 76:18-26.
37. Kaiser A., Schultheiss T.E., Wong J.Y., et al. Pitch, roll, and yaw variations in patient positioning. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66:949-955.
38. Dehnad H., Nederveen A.J., van der Heide U.A., et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother. Oncol. 2003, 67:295-302.
39. Stroom J.C., Koper P.C., Korevaar G.A., et al. Internal organ motion in prostate cancer patients treated in prone and supine treatment position. Radiother. Oncol. 1999, 51:237-248.
40. Antolak J.A., Rosen I.I., Childress C.H., et al. Prostate target volume variations during a course of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1998, 42:661-672.